Products for Research Use Only
RegisterLogin

GY1-22

CAT: 0013-GTR19212050-01Size: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19212050-01Size:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
GY1-22 is a small molecule inhibitor that disrupts the interaction between DNAJA1 and the oncogenic mutant p53 R175H. It is a research tool for studying mutant p53 gain-of-function mechanisms and has shown potential in vitro for impairing cancer cell viability, supporting its investigation in oncology and targeted therapy research.
CAS Number
326903-84-8
Field of Research
Cell Biology
Smiles
C (COC1=CC=CC=C1) N2C=3C (N=C2SCC=4NC=5C (N4) =CC=CC5) =CC=CC3
Molecular Formula
C23H20N4OS
Molecular Weight
400.5
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19149369-01Recombinant Glycine max Glycinin G1 (GY1), partial
GTR19277022-0122-Methoxy-22-oxodocosanoic acid
GTR19022878-01Recombinant Mouse Interleukin-22/IL-22
GTR19023232-01Recombinant Human Interleukin-22/IL-22
GTR19221410-01EGFR-IN-22
GTR19220010-01PRMT5-IN-22
GTR19218747-01CDK7-IN-22
GTR19218713-01NLRP3-IN-22
GTR19211376-01STK-22
GTR19208805-01SF-22

Alternative Products

CatalogName
MBS5815631GY1-22
MBS1204835-01Recombinant Glycine max Glycinin G1 (GY1)
CSB-EP356358GGV-01Recombinant Glycine max Glycinin G1 (GY1), partial
EPGY101Reagecon GY1 Colour Reference Solution according to European Pharmacopoeia (EP)
245300DGCR8 (DiGeorge Syndrome Critical Region Gene 8, C22orf12, DGCRK6, Gy1)
EPRSGYAMPSETReagecon GY1 to GY7 Colour Reference Set according to European Pharmacopoeia (EP)
TRC-B119586-25MGDocosanoic-22,22,22-d3 Acid
210453-01DGCR8 (DiGeorge Syndrome Critical Region 8, Gy1, pasha, DGCRK6, C22orf12) discontinued
MBS6413993-01DGCR8 (DiGeorge Syndrome Critical Region 8, Gy1, pasha, DGCRK6, C22orf12) (HRP)
MBS6413990-01DGCR8 (DiGeorge Syndrome Critical Region 8, Gy1, pasha, DGCRK6, C22orf12) (APC)

Popular Products